Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Prostatic Neoplasms 3Toxemia 1Stomach Neoplasms 1Rectal Neoplasms 1Primary Ovarian Insufficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Pancreatic Neoplasms 1Neoplasms 1Myocarditis 1Muscle Weakness 1Hematologic Neoplasms 1Gastrointestinal Neoplasms 1Diabetes, Gestational 1Colonic Neoplasms 1Cardiovascular Diseases 1Breast Neoplasms 1Brain Neoplasms 1Adenocarcinoma 1

Interventions

Cyclophosphamide 7Specimen Handling 5fludarabine 4Standard of Care 4trametinib 3Practice Guidelines as Topic 3Magnetic Resonance Spectroscopy 3GSK2636771 3Biopsy 3venetoclax 2talquetamab 2osimertinib 2dabrafenib 2capivasertib 2binimetinib 2X-Rays 2Thiotepa 2Tacrolimus 2Patient Navigation 2Nivolumab 2Mycophenolic Acid 2Methods 2Mesna 2Melphalan 2Filgrastim 2Educational Status 2Early Intervention, Educational 2Crizotinib 2Ado-Trastuzumab Emtansine 22-(3-(2-(1-isopropyl-3-methyl-1H-1,2-4-triazol-5-yl)-5,6-dihydrobenzo(f)imidazo(1,2-d)(1,4)oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hematologic Neoplasms × Positron-Emission Tomography × 30 days × Clear all
NCT06566209 2026-05-08

FDG-PET as an Imaging Modality to Diagnose and Risk Stratify Subclinical, Imaging Negative Ici-Myocarditis

Mayo Clinic

Terminated
2 enrolled
Other hematologic neoplasm

Myocarditis, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡